Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Natural Killer Cells Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 NK Cell Therapies
    • 1.4.3 NK Cell Directed Antibodies
  • 1.5 Market by Application
    • 1.5.1 Global Natural Killer Cells Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Research Centers & Institutes
    • 1.5.3 Hospitals
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Natural Killer Cells Therapeutics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Natural Killer Cells Therapeutics Industry
      • 1.6.1.1 Natural Killer Cells Therapeutics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Natural Killer Cells Therapeutics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Natural Killer Cells Therapeutics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Natural Killer Cells Therapeutics Market Perspective (2015-2026)
  • 2.2 Natural Killer Cells Therapeutics Growth Trends by Regions
    • 2.2.1 Natural Killer Cells Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Natural Killer Cells Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Natural Killer Cells Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Natural Killer Cells Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Natural Killer Cells Therapeutics Players by Market Size
    • 3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Natural Killer Cells Therapeutics Market Concentration Ratio
    • 3.2.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2019
  • 3.3 Natural Killer Cells Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Natural Killer Cells Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Natural Killer Cells Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2021-2026)

5 Natural Killer Cells Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global Natural Killer Cells Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Natural Killer Cells Therapeutics Market Size (2015-2020)
  • 6.2 Natural Killer Cells Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Natural Killer Cells Therapeutics Market Size (2015-2020)
  • 7.2 Natural Killer Cells Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Natural Killer Cells Therapeutics Market Size (2015-2020)
  • 8.2 Natural Killer Cells Therapeutics Key Players in China (2019-2020)
  • 8.3 China Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Natural Killer Cells Therapeutics Market Size (2015-2020)
  • 9.2 Natural Killer Cells Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Natural Killer Cells Therapeutics Market Size (2015-2020)
  • 10.2 Natural Killer Cells Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Natural Killer Cells Therapeutics Market Size (2015-2020)
  • 11.2 Natural Killer Cells Therapeutics Key Players in India (2019-2020)
  • 11.3 India Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Natural Killer Cells Therapeutics Market Size (2015-2020)
  • 12.2 Natural Killer Cells Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Affimed
    • 13.1.1 Affimed Company Details
    • 13.1.2 Affimed Business Overview and Its Total Revenue
    • 13.1.3 Affimed Natural Killer Cells Therapeutics Introduction
    • 13.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2015-2020))
    • 13.1.5 Affimed Recent Development
  • 13.2 Celgene Corporation
    • 13.2.1 Celgene Corporation Company Details
    • 13.2.2 Celgene Corporation Business Overview and Its Total Revenue
    • 13.2.3 Celgene Corporation Natural Killer Cells Therapeutics Introduction
    • 13.2.4 Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
    • 13.2.5 Celgene Corporation Recent Development
  • 13.3 Fate Therapeutics
    • 13.3.1 Fate Therapeutics Company Details
    • 13.3.2 Fate Therapeutics Business Overview and Its Total Revenue
    • 13.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
    • 13.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
    • 13.3.5 Fate Therapeutics Recent Development
  • 13.4 Fortress Biotech
    • 13.4.1 Fortress Biotech Company Details
    • 13.4.2 Fortress Biotech Business Overview and Its Total Revenue
    • 13.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
    • 13.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
    • 13.4.5 Fortress Biotech Recent Development
  • 13.5 Glycostem Therapeutics
    • 13.5.1 Glycostem Therapeutics Company Details
    • 13.5.2 Glycostem Therapeutics Business Overview and Its Total Revenue
    • 13.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
    • 13.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
    • 13.5.5 Glycostem Therapeutics Recent Development
  • 13.6 Innate Pharma
    • 13.6.1 Innate Pharma Company Details
    • 13.6.2 Innate Pharma Business Overview and Its Total Revenue
    • 13.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
    • 13.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
    • 13.6.5 Innate Pharma Recent Development
  • 13.7 Nantkwest
    • 13.7.1 Nantkwest Company Details
    • 13.7.2 Nantkwest Business Overview and Its Total Revenue
    • 13.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
    • 13.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
    • 13.7.5 Nantkwest Recent Development
  • 13.8 Nkarta Therapeutics
    • 13.8.1 Nkarta Therapeutics Company Details
    • 13.8.2 Nkarta Therapeutics Business Overview and Its Total Revenue
    • 13.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
    • 13.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
    • 13.8.5 Nkarta Therapeutics Recent Development
  • 13.9 NKT Therapeutics
    • 13.9.1 NKT Therapeutics Company Details
    • 13.9.2 NKT Therapeutics Business Overview and Its Total Revenue
    • 13.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
    • 13.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
    • 13.9.5 NKT Therapeutics Recent Development
  • 13.10 Ziopharm Oncology
    • 13.10.1 Ziopharm Oncology Company Details
    • 13.10.2 Ziopharm Oncology Business Overview and Its Total Revenue
    • 13.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
    • 13.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
    • 13.10.5 Ziopharm Oncology Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Natural Killer Cells Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Natural Killer Cells Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Affimed
    Celgene Corporation
    Fate Therapeutics
    Fortress Biotech
    Glycostem Therapeutics
    Innate Pharma
    Nantkwest
    Nkarta Therapeutics
    NKT Therapeutics
    Ziopharm Oncology

    Market segment by Type, the product can be split into
    NK Cell Therapies
    NK Cell Directed Antibodies
    Market segment by Application, split into
    Research Centers & Institutes
    Hospitals
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Natural Killer Cells Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the Natural Killer Cells Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Natural Killer Cells Therapeutics are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now